These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1435889)

  • 1. Should healthy women take tamoxifen?
    Fugh-Berman A; Epstein S
    N Engl J Med; 1992 Nov; 327(22):1596-7. PubMed ID: 1435889
    [No Abstract]   [Full Text] [Related]  

  • 2. Tamoxifen for prevention of breast cancer.
    Med Lett Drugs Ther; 1999 Jan; 41(1043):1-2. PubMed ID: 9924486
    [No Abstract]   [Full Text] [Related]  

  • 3. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
    Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
    Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is there a basis for prevention of breast cancer with drugs?].
    Klemetsdal B
    Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1493-5. PubMed ID: 9198929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.
    Duggan C; Marriott K; Edwards R; Cuzick J
    J Clin Oncol; 2003 Oct; 21(19):3588-93. PubMed ID: 14512389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention Trial.
    Giles K; Flynn PJ; Dalton R; Zera R
    Minn Med; 1993 Dec; 76(12):25-7. PubMed ID: 8127293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
    Brewster AM; Christo DK; Lai H; Helzlsouer K
    Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results.
    Crowell EB; Jubelirer SJ
    W V Med J; 2000; 96(6):598-601. PubMed ID: 11194088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen for the prevention of breast cancer: no.
    DeGregorio MW; Maenpaa JU; Wiebe VJ
    Important Adv Oncol; 1995; ():175-85. PubMed ID: 7672804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Can tamoxifen prevent breast cancer?].
    Delaloye JF
    Rev Med Suisse Romande; 1995 May; 115(5):361-3. PubMed ID: 7770680
    [No Abstract]   [Full Text] [Related]  

  • 12. Tamoxifen and breast cancer--from palliation to prevention.
    Rich SE
    Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
    Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
    J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer prevention trial will recruit 16,000 women.
    Oncology (Williston Park); 1992 Jul; 6(7):57-8. PubMed ID: 1386240
    [No Abstract]   [Full Text] [Related]  

  • 15. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
    Bradbury BD; Lash TL; Kaye JA; Jick SS
    Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen: a caveat on the pro side of the debate.
    Pressler VM
    Hawaii Med J; 1993 Apr; 52(4):90-4, 98. PubMed ID: 8500989
    [No Abstract]   [Full Text] [Related]  

  • 17. Tamoxifen: a caveat on the con side of the debate.
    Moser SM
    Hawaii Med J; 1993 Apr; 52(4):87-8, 102. PubMed ID: 8500988
    [No Abstract]   [Full Text] [Related]  

  • 18. Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy.
    Veronesi U; Maisonneuve P; Rotmensz N; Bonanni B; Boyle P; Viale G; Costa A; Sacchini V; Travaglini R; D'Aiuto G; Oliviero P; Lovison F; Gucciardo G; del Turco MR; Muraca MG; Pizzichetta MA; Conforti S; Decensi A;
    J Natl Cancer Inst; 2007 May; 99(9):727-37. PubMed ID: 17470740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen prophylaxis in breast cancer.
    Love RR
    Oncology (Williston Park); 1992 Jul; 6(7):33-8; discussion 38-40, 43. PubMed ID: 1386239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen for the prevention of breast cancer in high-risk women.
    Sweeney FW; Newton WP
    J Fam Pract; 1999 Feb; 48(2):90-1. PubMed ID: 10037532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.